American International Group Inc. Sells 1,230 Shares of CME Group Inc. (NASDAQ:CME)

American International Group Inc. decreased its position in shares of CME Group Inc. (NASDAQ:CME) by 1.1% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 112,017 shares of the financial services provider’s stock after selling 1,230 shares during the quarter. American International Group Inc.’s holdings in CME Group were worth $24,116,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Gold Investment Management Ltd. bought a new position in CME Group in the 4th quarter worth about $26,000. Northwest Financial Advisors bought a new position in CME Group in the 4th quarter worth about $28,000. Salomon & Ludwin LLC bought a new position in CME Group in the 1st quarter worth about $28,000. Harbor Investment Advisory LLC boosted its stake in CME Group by 966.7% in the 4th quarter. Harbor Investment Advisory LLC now owns 160 shares of the financial services provider’s stock worth $34,000 after purchasing an additional 145 shares during the period. Finally, Rise Advisors LLC bought a new position in CME Group in the 1st quarter worth about $41,000. Institutional investors own 87.75% of the company’s stock.

Insider Transactions at CME Group

In other news, Director Daniel R. Glickman sold 650 shares of CME Group stock in a transaction that occurred on Thursday, June 6th. The stock was sold at an average price of $201.44, for a total value of $130,936.00. Following the sale, the director now directly owns 14,008 shares in the company, valued at approximately $2,821,771.52. The sale was disclosed in a filing with the SEC, which is available through this link. In other CME Group news, CEO Terrence A. Duffy sold 40,000 shares of the business’s stock in a transaction on Monday, April 29th. The stock was sold at an average price of $210.91, for a total value of $8,436,400.00. Following the sale, the chief executive officer now directly owns 67,455 shares of the company’s stock, valued at $14,226,934.05. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Daniel R. Glickman sold 650 shares of the business’s stock in a transaction on Thursday, June 6th. The stock was sold at an average price of $201.44, for a total value of $130,936.00. Following the completion of the sale, the director now directly owns 14,008 shares in the company, valued at $2,821,771.52. The disclosure for this sale can be found here. In the last three months, insiders have sold 54,290 shares of company stock worth $11,393,700. 0.30% of the stock is currently owned by insiders.

CME Group Price Performance

Shares of NASDAQ CME traded down $0.19 during trading hours on Wednesday, reaching $197.25. 2,688,366 shares of the stock traded hands, compared to its average volume of 1,967,880. The company has a market capitalization of $71.02 billion, a P/E ratio of 22.44, a price-to-earnings-growth ratio of 6.65 and a beta of 0.52. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 0.10. CME Group Inc. has a 52-week low of $189.85 and a 52-week high of $223.80. The company’s 50-day simple moving average is $200.38 and its two-hundred day simple moving average is $206.98.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, April 24th. The financial services provider reported $2.50 EPS for the quarter, topping analysts’ consensus estimates of $2.44 by $0.06. The business had revenue of $1.49 billion for the quarter, compared to analysts’ expectations of $1.48 billion. CME Group had a return on equity of 12.45% and a net margin of 56.84%. The business’s quarterly revenue was up 3.2% on a year-over-year basis. During the same period in the previous year, the firm earned $2.42 EPS. Equities research analysts forecast that CME Group Inc. will post 9.77 EPS for the current year.

CME Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 25th. Shareholders of record on Friday, June 7th were paid a $1.15 dividend. The ex-dividend date of this dividend was Friday, June 7th. This represents a $4.60 dividend on an annualized basis and a yield of 2.33%. CME Group’s dividend payout ratio (DPR) is currently 52.33%.

Analysts Set New Price Targets

Several research analysts have commented on CME shares. Barclays cut their target price on CME Group from $228.00 to $208.00 and set an “equal weight” rating for the company in a research note on Wednesday, July 10th. JPMorgan Chase & Co. downgraded CME Group from a “neutral” rating to an “underweight” rating and dropped their price target for the company from $206.00 to $187.00 in a research report on Friday, June 21st. Bank of America lifted their price target on CME Group from $209.00 to $216.00 and gave the company a “neutral” rating in a research report on Thursday, April 25th. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and set a $210.00 price target (down previously from $235.00) on shares of CME Group in a research report on Friday, April 5th. Finally, Morgan Stanley lifted their price target on CME Group from $222.00 to $225.00 and gave the company an “equal weight” rating in a research report on Tuesday, April 9th. Three investment analysts have rated the stock with a sell rating, six have issued a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $215.82.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.